BioRestorative Therapies (BRTX) Other Operating Expenses (2010 - 2021)
BioRestorative Therapies' (BRTX) quarterly Other Operating Expenses came in at -$18590.0 in Q3 2021, down 155.09% on a YoY basis from $33744.0 in Q3 2020, and down 336.27% quarter-over-quarter from $7868.0 in Q2 2021.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Other Operating Expenses (2010 - 2021) Analysis & Trends
BioRestorative Therapies (BRTX) has reported Other Operating Expenses for 12 consecutive years, with -$18590.0 the latest figure, recorded in Q3 2021.
- For the quarter ending Q3 2021, Other Operating Expenses fell 155.09% year-over-year to -$18590.0; the trailing twelve-month figure through Jun 2022 stood at -$18590.0 (down 120.97% YoY), and the FY2020 full-year result was $165531.0, down 92.59% from the prior year.
- Other Operating Expenses eased to -$18590.0 in Q3 2021 per BRTX's latest filing, from $7868.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $884362.0 in Q2 2017 and bottomed at -$18590.0 in Q3 2021.
- Historically, Other Operating Expenses has averaged $369603.2 across 5 years, with a median of $473953.0 in 2018.
- The sharpest annual moves came in 2017 and 2021: Other Operating Expenses surged 60.48% in 2017, then plunged 155.09% in 2021.
- Over 5 years, Other Operating Expenses stood at $491195.0 in 2017, then soared by 50.82% to $740833.0 in 2018, then slumped by 39.86% to $445516.0 in 2019, then sank by 91.91% to $36055.0 in 2020, then plunged by 151.56% to -$18590.0 in 2021.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$18590.0, $7868.0, and $10989.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | BioRestorative Therapies | 62,133.68 | -2.89 Mn | 17,964.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | -18,590.00 |
| Jun 30, 2021 | 7,868.00 |
| Mar 31, 2021 | 10,989.00 |
| Dec 31, 2020 | 36,055.00 |
| Sep 30, 2020 | 33,744.00 |
| Jun 30, 2020 | 39,712.00 |
| Mar 31, 2020 | 56,020.00 |
| Dec 31, 2019 | 445,516.00 |
| Sep 30, 2019 | 530,154.00 |
| Jun 30, 2019 | 642,722.00 |
| Mar 31, 2019 | 615,571.00 |
| Dec 31, 2018 | 740,833.00 |
| Sep 30, 2018 | 572,762.00 |
| Jun 30, 2018 | 435,485.00 |
| Mar 31, 2018 | 473,953.00 |
| Dec 31, 2017 | 491,195.00 |
| Sep 30, 2017 | 530,905.00 |
| Jun 30, 2017 | 884,362.00 |
| Mar 31, 2017 | 493,205.00 |
| Dec 31, 2016 | 363,511.00 |